PatentsGlobal
BioMark Diagnostics Obtains Key Canadian and European Patents for Innovative Lung Cancer Blood Test
BioMark Diagnostics Inc. has secured formal patent allowances from the Canadian Intellectual Property Office and the European Patent Office for its novel liquid biopsy technology aimed at early-stage lung cancer detection. The patented algorithm, clinically validated on samples from Quebec, France, and Germany, enhanc…
Tuesday, June 23, 2026